| 000 | 017350000a22003490004500 | ||
|---|---|---|---|
| 003 | EG-GICUC | ||
| 005 | 20250223025311.0 | ||
| 008 | 080601s2008 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GICUC _beng _cEG-GICUC |
||
| 041 | 0 | _aEng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.29.M.Sc.2008.Em.P | ||
| 100 | 0 | _aEman Abdelsalam Abdelazim Badawy | |
| 245 | 1 | 0 |
_aPossible antithrombotic properties of rosiglitazone - Aperoxisome proliferator activated receptor - y PPARy activator - independent of ITS glycemic control in rats / _cEman Abdelsalam Abdelazim Badawy ; Supervised Mohsen Samy Selim , Magdi Ishak , Hind Mohamed Moataz Elsherbini |
| 246 | 1 | 5 | _aالخاصية الممكنة المضادة للصفائح الدموية للروزيجليتازون دون الاعتماد على تأثيره المنظم للسكر فى الدم لدى الجرذان |
| 260 |
_aCairo : _bEman Abdelsalam Abdelazim Badawy , _c2008 |
||
| 300 |
_a112P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty Of Medicine - Department Of Pharmacology | ||
| 520 | _aRosiglitazone is a peroxisome proliherator - activated receptor - y agonist that has an important role in regulating blood glucose and lipid levels thus improving insulin resulin resistance in diabetic patients type II | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aPlatelets | |
| 653 | 4 | _aPPAR - Y | |
| 653 | 4 | _aRosiglitazone | |
| 700 | 0 |
_aHind Mohamed Moataz Elsherbini , _eSupervisor |
|
| 700 | 0 |
_aMagdi Ishak , _eSupervisor |
|
| 700 | 0 |
_aMohsen Samy Selim , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSoheir _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c9981 _d9981 |
||